Dna X Inc (SONM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 0 | 16,214 | 11,190 | 16,721 | 0 |
| Cost of Goods | -33,108 | 14,398 | 10,345 | 8,365 | -33,211 |
| Gross Profit | -11,017 | 1,816 | 845 | 8,356 | -10,103 |
| Operating Expenses | -15,786 | 6,194 | 7,922 | 8,076 | -18,749 |
| Operating Income | 4,661 | -3,980 | -6,732 | 645 | 8,435 |
| Interest Expense | 484 | 522 | 389 | 91 | 12 |
| Other Income | -723 | -161 | -215 | 36 | 449 |
| Pre-tax Income | 3,454 | -4,663 | -7,336 | 590 | 8,872 |
| Income Tax | N/A | 90 | 139 | 132 | N/A |
| Net Income Continuous | 3,815 | -4,753 | -7,475 | 458 | 9,151 |
| Net Income | $-8,887 | $-4,753 | $-7,475 | $458 | $-21,614 |
| EPS Basic Total Ops | -10.98 | -4.83 | -14.21 | 1.44 | -82.00 |
| EPS Basic Continuous Ops | 6.55 | -4.83 | -14.14 | 1.41 | 35.50 |
| EPS Diluted Total Ops | -10.98 | -4.83 | -14.21 | 1.44 | -82.00 |
| EPS Diluted Continuous Ops | 6.56 | -4.83 | -14.14 | 1.40 | 35.50 |
| EPS Diluted Before Non-Recurring Items | N/A | -3.86 | -10.97 | 1.44 | N/A |
| EBITDA(a) | $50,282 | $-3,028 | $-5,935 | $1,700 | $52,663 |